GPR84 and neoplasm: To investigate the transcriptional programs that underlie this difference, we performed scRNA-seq on tumor-infiltrating immune cells from Gpr84+/+ and Gpr84−/− MC38 tumor-bearing mice on day 21 past inoculation (Fig. 3B).